156 related articles for article (PubMed ID: 1061104)
1. A normal level of adenosine deaminase activity in the red cell lysates of carriers and patients with severe combined immunodeficiency disease.
Trotta PP; Smithwick EM; Balis ME
Proc Natl Acad Sci U S A; 1976 Jan; 73(1):104-8. PubMed ID: 1061104
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunochemical quantitation of human adenosine deaminase.
Daddona PE; Frohman MA; Kelley WN
J Clin Invest; 1979 Sep; 64(3):798-803. PubMed ID: 468994
[TBL] [Abstract][Full Text] [Related]
3. Characterization of residual enzyme activity in fibroblasts from patients with adenosine deaminase deficiency and combined immunodeficiency: evidence for a mutant enzyme.
Hirschhorn R; Beratis N; Rosen FS
Proc Natl Acad Sci U S A; 1976 Jan; 73(1):213-7. PubMed ID: 1061119
[TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase deficiency in combined immunologic deficiency disease.
Meuwissen HJ; Pickering RJ; Pollara B
Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
[TBL] [Abstract][Full Text] [Related]
5. Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.
Agarwal RP; Crabtree GW; Parks RE; Nelson JA; Keightley R; Parkman R; Rosen FS; Stern RC; Polmar SH
J Clin Invest; 1976 Apr; 57(4):1025-35. PubMed ID: 947948
[TBL] [Abstract][Full Text] [Related]
6. Hereditary sever combined immunodeficiency and adenosine deaminase deficiency.
Ackeret C; Llüss HJ; Hitzig WH
Pediatr Res; 1976 Jan; 10(1):67-70. PubMed ID: 1246464
[TBL] [Abstract][Full Text] [Related]
7. The function of adenosine deaminase in the human erythrocyte.
Perrett D; Dean B
Biochem Biophys Res Commun; 1977 Jul; 77(1):374-8. PubMed ID: 883983
[No Abstract] [Full Text] [Related]
8. Characterization of the residual adenosine deaminating activity in the spleen of a patient with combined immunodeficiency disease and adenosine deaminase deficiency.
Schrader WP; Pollara B; Meuwissen HJ
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):446-50. PubMed ID: 24216
[TBL] [Abstract][Full Text] [Related]
9. Use of the integrated steady state rate equation to investigate product inhibition of human red cell adenosine deaminase and its relevance to immune dysfunction.
Osborne WR; Chen SH; Scott CR
J Biol Chem; 1978 Jan; 253(2):323-5. PubMed ID: 618871
[TBL] [Abstract][Full Text] [Related]
10. Electrophoretic separation of erythrocyte adenosine deaminase in three families with severe combined immunodeficiency.
Gutter GP; Plüss HJ; Hitzig WH
Res Exp Med (Berl); 1978 Sep; 173(3):219-28. PubMed ID: 725324
[No Abstract] [Full Text] [Related]
11. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency.
Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW
Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of adenosine deaminase from human erythrocytes.
Körber W; Meisterernst EB; Hermann G
Clin Chim Acta; 1975 Sep; 63(3):323-33. PubMed ID: 240521
[TBL] [Abstract][Full Text] [Related]
13. Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia.
Glader BE; Backer K; Diamond LK
N Engl J Med; 1983 Dec; 309(24):1486-90. PubMed ID: 6646173
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme.
Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W
J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373
[TBL] [Abstract][Full Text] [Related]
15. Adenosine deaminase deficiency and immunodeficiencies.
Hirschhorn R
Fed Proc; 1977 Jul; 36(8):2166-70. PubMed ID: 872949
[TBL] [Abstract][Full Text] [Related]
16. Prenatal detection of a probable heterozygote for ADA deficiency and severe combined immunodeficiency disease using a microradioassay.
Aitken DA; Kleijer WJ; Niermeijer MF; Herbschleb-Voogt E; Galjaard H
Clin Genet; 1980 Apr; 17(4):293-8. PubMed ID: 7371221
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of an aminohydrolase distinct from adenosine deaminase in cultured human lymphoblasts.
Daddona PE; Kelley WN
Biochim Biophys Acta; 1981 Apr; 658(2):280-90. PubMed ID: 6972784
[TBL] [Abstract][Full Text] [Related]
18. Physical and catalytic properties of the isozymes of adenosine deaminase from human red blood cells.
MacQuarrie R; Buel E
Mol Cell Biochem; 1982 Oct; 48(2):121-6. PubMed ID: 7144744
[TBL] [Abstract][Full Text] [Related]
19. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
Hershfield MS; Buckley RH; Greenberg ML; Melton AL; Schiff R; Hatem C; Kurtzberg J; Markert ML; Kobayashi RH; Kobayashi AL
N Engl J Med; 1987 Mar; 316(10):589-96. PubMed ID: 3807953
[TBL] [Abstract][Full Text] [Related]
20. A family of adenosine deaminase deficiency with severe combined immunodeficiency.
Tsuchiya S; Narisawa K; Konno T; Tada K
Jinrui Idengaku Zasshi; 1979 Jun; 24(2):95-8. PubMed ID: 529554
[No Abstract] [Full Text] [Related]
[Next] [New Search]
